Announcements - Chinese Clinical Oncology

Posted: 2026-06-23

New Impact Factor for Chinese Clinical Oncology: 2.7

We are pleased to announce that the Chinese Clinical Oncology (CCO) has attained its latest impact factor for the 2025 citation year: 2.7.

Posted: 2026-06-18

Chinese Clinical Oncology 2025 CiteScore Released: 3.4

We are pleased to announce that the Chinese Clinical Oncology (CCO) has achieved its 2025 CiteScore: 3.4, ranking 248 out of 428 journals in the Oncology category.

Posted: 2026-04-01

Welcome to the 2026 Clinical Research Innovation Forum & Editors-in-Chief Meet-and-Greet

We are pleased to invite you to join the 2026 Clinical Research Innovation Forum & Editors-in-Chief Meet-and-Greet co-organized by AME Publishing Company and Wolters Kluwer.The event will take place in the Crystal Court at Hopewell Hotel, Hong Kong, on March 28, 2026.
This forum brings together leading researchers and Editors-in-Chief from distinguished journals worldwide to drive innovation in clinical research and foster high-level academic exchange.

Posted: 2026-01-08

CCO Annual Report (2025)

We are glad to present a brief introduction of CCO’s progress in 2025 here. CCO has an international editorial board comprising 56 members from 14 countries, including USA (50%), China (9%), Italy (9%), Japan (7%), among others.

Posted: 2025-11-12

Join us at the 9th World Congress of Pediatric Cardiology & Cardiac Surgery

The 9th World Congress of Pediatric Cardiology & Cardiac Surgery (WCPCCS) is going to be held at the Hong Kong Convention and Exhibition Centre, Hong Kong, China from December 7 to 12, 2025: www.wcpccs2025.org.

Posted: 2025-10-08

AME and Wolters Kluwer aim to expand access to global medical research through new collaboration

The agreement broadens the reach of nearly 50 Open Access titles, contributing globally to over 5,000 articles

Posted: 2025-06-19

New Impact Factor for Chinese Clinical Oncology: 2.5

We are pleased to announce that the Chinese Clinical Oncology (CCO) has attained its latest impact factor for the 2024 citation year: 2.5.

Posted: 2025-06-17

Chinese Clinical Oncology 2024 CiteScore Released: 3

We are pleased to announce that the Chinese Clinical Oncology (CCO) has achieved its 2024 CiteScore: 3, ranking 251 out of 415 journals in the Oncology category. This milestone underscores our ongoing commitment to publishing impactful research in the field.

Posted: 2025-03-07

Join us at the 33rd Annual Meeting of the European Society of Thoracic Surgery (ESTS)

Posted: 2025-02-11

Join us at the 105th Annual Meeting of American Association for Thoracic Surgery (AATS)

The 105th Annual Meeting of American Association for Thoracic Surgery (AATS) is going to be held at the Seattle Convention Center, Seattle, WA, USA from May 2 to 5, 2025: https://events.aats.org/am25.

Posted: 2025-01-09

CCO Annual Report (2024)

We are glad to present a brief introduction of CCO’s progress in 2024 here.

Posted: 2024-07-24

19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting

The 19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting will be held at the One Farrer Hotel, Singapore from 16 – 18 August 2024.

Posted: 2024-06-21

New Impact Factor for Chinese Clinical Oncology: 2.1

We are pleased to announce that the Chinese Clinical Oncology (CCO) has attained its latest impact factor for the 2023 citation year: 2.1.

Posted: 2024-06-14

Chinese Clinical Oncology 2023 CiteScore Released: 3.9

We are pleased to announce that the Chinese Clinical Oncology (CCO) has received its 2023 CiteScore: 3.9, ranking 212 out of 404 journals in the Oncology category.

Posted: 2024-01-11

CCO Annual Report (2023)

We are glad to present a brief introduction of CCO’s progress in 2023 here.

Posted: 2023-07-05

Chinese Clinical Oncology 2022 CiteScore Released: 4.3

We are pleased to announce that the Chinese Clinical Oncology (CCO) has received its 2022 CiteScore: 4.3, ranking 195 out of 830 journals in the General Medicine category.

Posted: 2023-06-28

The First Impact Factor for Chinese Clinical Oncology: 2.8

We are pleased to announce that the Chinese Clinical Oncology (CCO) has attained its first impact factor for the 2022 citation year: 2.8 (Figure 1).

Posted: 2023-04-21

Join us at the 103rd Annual Meeting of American Association for Thoracic Surgery (AATS)

Posted: 2023-03-15

Full implementation of transparent peer review at Chinese Clinical Oncology

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to fully implement the transparent peer review (TPR) process for all new submission from March 15, 2023.

Posted: 2023-02-08

CCO Annual Report (2022)

We are glad to present a brief introduction of CCO’s progress in 2022 here.

Posted: 2023-01-31

Welcome to join us at the 18^th St. Gallen International Breast Cancer Conference 2023, Vienna, Austria, 15 - 18 March!

The 18^th St. Gallen International Breast Cancer Conference 2023 will be held in Vienna, Austria this year during 15-18 March.

Posted: 2022-07-28

Chinese Clinical Oncology is going to receive its first impact factor in June 2023

According to the latest news of Web of Science, Clarivate Analytics on July 26, 2022, in the 2023 release of the Journal Citation Report™, all Web of Science Core Collection™ journals will receive a Journal Impact Factor (JIF)™.

Posted: 2022-01-25

CCO Annual Report (2021)

We are glad to present a brief introduction of CCO’s progress in 2021 here.

Posted: 2021-11-05

Chinese Clinical Oncology (CCO) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Chinese Clinical Oncology (CCO) is among the list of COPE membership.

Posted: 2021-01-22

CCO Annual Report (2020)

We are glad to present a brief introduction of CCO’s progress in 2020 here.